WuXi ends US biologics manufacture; focus on testing
WuXi PharmaTech is to discontinue its US biologics manufacturing operations as it attempts to cut costs, with 100 employees due to lose their jobs.
Archives for December 2, 2008
Quintiles gets bigger in cancer with TMD purchase
Quintiles Transnational has boosted its array of services for companies developing cancer drugs via the purchase of Illinois, US-based firm Targeted Molecular Diagnostics.
Domino’s unveils 5” printhead at Embellage
Domino Printing Sciences chose this year’s Emballage world packaging exhibition in Paris, France to showcase the new 5” printhead it has developed for its V300+ thermal transfer printer.
inVentive signs up to help GeneraMedix’ epoprostenol
inVentive Health has been contracted to provide marketing and branding services for fellow US based generic injectables developer GeneraMedix, specifically focusing on the latter’s epoprostenol hypertension treatment.
VenturiOne v3 launched for batch analysis
Applied Cytometry (AC) hopes its VenturiOne v3 software, which is capable of processing 400 files in under 10 seconds, will win over drug developers looking to expedite large-scale laboratory analysis.
Cheap ARVs to spark manufacturing in African
Research into developing manufacturing methods to produce cheap antiretrovirals in Africa has been highlighted on World Aids Day by The Council for Scientific and Industrial Research (CSIR).
Dow’s foam granulation used in second B-MS candidate
News that US drugmaker Bristol-Myers Squibb (B-MS) is using its Foam Granulation Technology (FGT) to develop a second drug has worked formulation specialist Dow Wolff Cellulosics (DWC) into quite a lather.
Roundtable discusses creating a biogeneric pathway
The challenges in establishing a regulatory pathway for biogenerics were discussed at a recent FTC roundtable, with a FDA official saying in most cases it will be “impossible” to establish that the APIs are identical.
Successful FDA inspection for NextPharma
NextPharma’s facility in Waltrop, Germany has undergone a successful inspection by the US Food and Drug Administration (FDA).